Venture capital investment syndication tool and market place

  • 4-7 Team Size
  • 2018 Founding Year
  • Zürich Location
  • Company, seed stage Project Status
  • leva.pe/ Website
  • Private Equity, Venture Capital, Financial Markets, fintech Markets

Leva is a tool that allows venture capitalists (e.g. business angels, accelerators, VC funds) to easily set up a syndicate. Our set-up process is automated and can be completed online. Our online tool allows to manage fundraising activities, share- and capital flows, and investor communication. Automated processes reduce time, effort, and money spent on setting up syndicates and managing investors. In the future, Leva will also provide a marketplace matching investors and asset managers (i.e. funds)



Three companies a step away from winning the Swiss Medtech Award

Aleva Neurotherapeutics, Rheon Medical or VirtaMed, one of the three companies will win the annual Swiss medtech Award prize of CHF 50,000. The finale will take place on 21 September 2020 in Bern.


Aleva secures a CE mark and $8 million

Aleva Neurotherapeutics’ flagship product, the directSTIMTM Deep Brain Stimulation System for neurological indications such as Parkinson’s disease and essential tremor is now CE Mark certified. The company has also raised USD 8 million in the first closing of a Series E financing round.


Aleva Neurotherapeutics forms joint venture with DIXI Medical

The new company, Adept Neuro, will develop a new generation of deep brain surgical electrodes for epilepsy treatment. DIXI Holding will finance the joint venture and gradually become the sole shareholder.


Adrian Kronauer